{"disease":{"id":"methylmalonic-acidemia-mma","name":"methylmalonic acidemia mma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07163364","title":"A Study to Evaluate the Effects and Safety of Hydroxocobalamin in Participants With Combined Methylmalonic Academia (cblC Type)","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","has_results":false},{"nct_id":"NCT04284917","title":"Long-term Efficacy of Carglumic Acid in Organic Acidemia.","phase":"NA","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT03810690","title":"Open Label Study of mRNA-3704 in Patients With Isolated Methylmalonic Acidemia","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"ModernaTX, Inc.","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}